Home NDC 59310-610 CINQAIR
Product NDC 59310-610
11-digit product format 593100610
Labeler code 59310
Product ID 59310-610_a509df2c-67b6-40c3-8b6d-f9de54b62c8a
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Reslizumab
Dosage form INJECTION, SOLUTION, CONCENTRATE
Route INTRAVENOUS
Labeler Teva Respiratory, LLC
Application BLA761033
Marketing category BLA
Marketing start 2016-04-18
Substance RESLIZUMAB
Active strength 10 mg/mL
Pharmacologic classes Interleukin-5 Antagonist [EPC], Interleukin-5 Antagonists [MoA]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base CINQAIR
Listing expiration 2027-12-31
Active Ingredients# Ingredient, Strength table Ingredient Strength RESLIZUMAB 10 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 35A26E427H Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1746893 Internal RxNorm lookup 1746898 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 59310-610-31 CINQAIR 10 mL in 1 VIAL, SINGLE-USE INJECTION, SOLUTION, CONCENTRATE 10 14 59310-610-31 CINQAIR 1 in 1 CARTON INJECTION, SOLUTION, CONCENTRATE 1 14 59310-610-33 CINQAIR 10 mL in 1 VIAL, SINGLE-USE INJECTION, SOLUTION, CONCENTRATE 10 14 59310-610-33 CINQAIR 1 in 1 CARTON INJECTION, SOLUTION, CONCENTRATE 1 14
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 59310-610 CINQAIR (RESLIZUMAB) INJECTION, SOLUTION, CONCENTRATE [TEVA RESPIRATORY, LLC] 10 Current NDC, Legacy NDC, 4 package rows 20200630_053b9158-2a5b-48b9-bf47-5fa78a35ec33.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761033 Cinqair reslizumab 351(a) Rx 2026-07-01
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 59310-610-31 59310061031 1 VIAL, SINGLE-USE in 1 CARTON (59310-610-31) / 10 mL in 1 VIAL, SINGLE-USE 2016-04-18 0000-00-00 No No Current 59310-610-33 59310061033 1 VIAL, SINGLE-USE in 1 CARTON (59310-610-33) > 10 mL in 1 VIAL, SINGLE-USE 2017-06-04 0000-00-00 Yes No Current